...
首页> 外文期刊>Current vascular pharmacology >Renal Dysfunction Following Elective Endovascular Aortic Aneurysm Repair
【24h】

Renal Dysfunction Following Elective Endovascular Aortic Aneurysm Repair

机译:择期血管内主动脉瘤修复术后肾功能不全

获取原文
获取原文并翻译 | 示例

摘要

Abdominal Aortic Aneurysm (AAA) is a degenerative disease of the aortic wall with potentially fatal complications. Open Repair (OR) was considered the gold standard, until the emergence of Endovascular Aneurysm Repair (EVAR), which is less invasive and equally (if not more) effective. As the popularity of endovascular procedures grows, related complications become more evident, with kidney damage being one of them. Although Acute Kidney Injury (AKI) following EVAR is relatively common, its true incidence is still uncertain. Also, there is insufficient data concerning long-term renal outcomes after EVAR, especially with repeated contrast agent exposure. Despite the lack of firm evidence on the effectiveness of individual strategies, it is evident that prevention of AKI following EVAR requires a multifactorial approach. This review focuses on recent findings based on human studies regarding the current evidence of renal impairment after EVAR, its quantification and strategies for its prevention.
机译:腹主动脉瘤 (AAA) 是一种主动脉壁退行性疾病,具有潜在的致命并发症。开放修复 (OR) 被认为是黄金标准,直到血管内动脉瘤修复 (EVAR) 的出现,它侵入性较小且同样(如果不是更多)有效。随着血管内手术的普及,相关并发症变得更加明显,肾脏损伤就是其中之一。尽管 EVAR 后的急性肾损伤 (AKI) 相对常见,但其真实发病率仍不确定。此外,关于EVAR后长期肾脏结局的数据不足,尤其是反复暴露造影剂时。尽管缺乏关于个别策略有效性的确切证据,但很明显,预防 EVAR 后的 AKI 需要多因素方法。本综述重点关注基于人体研究的最新发现,这些发现涉及EVAR后肾功能损害的当前证据、其量化和预防策略。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号